hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2028

Conditions

Alzheimer DiseaseParkinson DiseaseLewy Body DementiaMultiple System AtrophyFronto-temporal DementiaAmyotrophic Lateral Sclerosis

Interventions

DRUG

hUC-MSC-sEV-001 nasal drops

Trial Locations (1)

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors

lead

Xuanwu Hospital, Beijing

OTHER